Investigating the Effects of Nutrition on the Maturation of Brain Networks Associated With Memory in Infants
1 other identifier
interventional
60
1 country
1
Brief Summary
This project will investigate whether adding nutritional supplements to the diet will have beneficial effects on the development of infant brain networks (assessed at 4 and 9 months of age). The nutritional supplement will contain lutein (typically found in leafy vegetables),docosahexaenoic acid (DHA; a fatty acid typically found in cold-water fish such as salmon or tuna), and of vitamin E.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Feb 2015
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 5, 2015
CompletedFirst Posted
Study publicly available on registry
May 29, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedMay 4, 2017
May 1, 2017
3.8 years
February 5, 2015
May 1, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Brain Imaging (Event-Related Optical Signal) of breastfed 4 month old infant
The current project will investigate whether nutritional supplements will have beneficial effects on infant brain networks at 4 months of age. We will use the Event-Related Optical Signal (EROS) to non-invasively record brain activity in the infants as they passively listen to sounds (e.g., novel sounds, speech sounds, words, etc.) and watch short video clips of moving objects (e.g., toys, children playing, etc) to look at whether the nutritional supplement influences brain development.
Brain activity will be assessed at 4 months of age
Brain Imaging (Event-Related Optical Signal) of breastfed 9 month old infant
The current project will investigate whether nutritional supplements will have beneficial effects on infant brain networks at 9 months of age. We will use the Event-Related Optical Signal (EROS) to non-invasively record brain activity in the infants as they passively listen to sounds (e.g., novel sounds, speech sounds, words, etc.) and watch short video clips of moving objects (e.g., toys, children playing, etc) to look at whether the nutritional supplement influences brain development.
Brain activity will be assessed at 9 months of age
Secondary Outcomes (2)
Infant Dry Blood Spot at 4 months
4 months of age
Infant Dry Blood Spot at 9 months
9 months of age
Study Arms (2)
Postnatal Dietary Supplement
EXPERIMENTALDietary Supplement: docosahexaenoic acid, lutein, and α-tocopherol (vitamin E). 1 capsule per day will be consumed beginning immediately after birth and continuing for 9 months.
Control Supplement
PLACEBO COMPARATORControl Supplement: Capsule containing soybean oil and α-tocopheryl (vitamin E). 1 capsule per day will be consumed beginning immediately after birth and continuing for 9 months.
Interventions
Dietary Supplement: docosahexaenoic acid, lutein, and α-tocopherol (vitamin E). 1 capsule per day will be consumed beginning immediately after birth and continuing for 9 months.
Placebo Supplement:soybean oil and α-tocopherol (vitamin E)
Eligibility Criteria
You may qualify if:
- Intention to breast feed for at least the first 3 months
- years of age or older
- Willingness to abstain from multi-vitamins or other supplements that contain lutein and vitamin E during the study and take no more than 200 mg of DHA.
- Normal or corrected-to-normal vision
- Normal or corrected-to-normal hearing
- English is the dominant language spoken in the home.
You may not qualify if:
- and/or early termination:
- Mother is taking cholesterol medication and/or medication affecting lipid absorption and/or transport.
- High risk pregnant mothers
- Macular Pigment Optical Density (MPOD) score greater than 0.6.
- Preterm birth (less than 37 weeks)
- Low birth weight (less than 2500 grams, \< 5.5 pounds)
- Unable or unwilling to continue breast feeding within the first 3 months after birth.
- Unable or unwilling to continue taking the study supplement within the first 3 months after birth.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beckman Institute
Urbana, Illinois, 61801, United States
Related Publications (2)
Sherry CL, Oliver JS, Renzi LM, Marriage BJ. Lutein supplementation increases breast milk and plasma lutein concentrations in lactating women and infant plasma concentrations but does not affect other carotenoids. J Nutr. 2014 Aug;144(8):1256-63. doi: 10.3945/jn.114.192914. Epub 2014 Jun 4.
PMID: 24899160BACKGROUNDGratton G, Fabiani M. Fast optical imaging of human brain function. Front Hum Neurosci. 2010 Jun 23;4:52. doi: 10.3389/fnhum.2010.00052. eCollection 2010.
PMID: 20631845BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Gabriele Gratton, Ph.D., M.D.
University of Illinois at Chicago
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2015
First Posted
May 29, 2015
Study Start
February 1, 2015
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
May 4, 2017
Record last verified: 2017-05